On August 14, the U.S. Army posted the Countering Weapons of Mass Destruction (CWMD) Other Transaction Agreement (OTA) Combined Synopsis/Solicitation (Solicitation Number: W15QKN-17-R-0AV2). Responses are due by September 4, according to FedBizOpps.
The Army Contracting Command – New Jersey (ACC-NJ), on behalf of the Office of the Assistant Secretary of the Army for Acquisition, Logistics, and Technology (ASA(ALT)) and the Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) is releasing this competitive combined synopsis/solicitation to establish a Section 815 Other Transaction Agreement (OTA) for Prototype Projects under 10 U.S.C. 2371b with a new or established consortium, to develop and mature technologies in the critical field of Countering Weapons of Mass Destruction (CWMD).
It is the Government’s intention to enter into an OTA with only one (1) consortium that can best meet the Government’s defined scope provided below. By definition, the consortium is an organized group of entities that agree to participate under a common rule set. The consortium should be open to new membership and display a broad array of expertise and experience connected to the domains identified herein. Prospective members must agree to the terms of the consortium. A consortium comprised of educational, nonprofit, and commercial organizations with broad and open membership is required to provide the Government a partner able to collaborate across barriers that include military/civilian, public/private, local/regional/national, and political/jurisdictional concerns.
The Government, in conjunction with the consortium, shall perform prototype projects designed to enhance mission effectiveness and to develop and mature technologies in the field of countering weapons of mass destruction. Possible requirements would encompass activities that span all phases of acquisition as described in the DODI 5000.02, from the development and execution of the Materiel Development Decision (MDD) through the Materiel Solution Analysis (MSA) Phase, Technical Maturation/Risk Reduction (TMRR) Phase, Engineering and Manufacturing Phase (EMD) as well as the award of potential follow-on Production and Deployment contracts and instruments (including both Low Rate Initial Production (LRIP) and Full Rate Production (FRP)).
Full information is available here.